Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Feb 27, 2025
CANTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and sports medicine markets, today reported financial results for the fourth quarter and the year ended December 31, 2024.
Read more at globenewswire.com
